Sessa Capital Im, L.P. Bristol Myers Squibb CO Call Options Transaction History

Sessa Capital Im, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $39.2 Million - $46.8 Million	-869,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $31.7 Million - $41.1 Million	-649,900 Reduced 42.79%	869,000 $45.2 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $163 Million - $184 Million	-2,960,600 Reduced 66.09%	1,518,900 $94.3 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $20.2 Million - $25.2 Million	-400,000 Reduced 8.2%	4,479,500 $248 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $21 Million - $24.1 Million	350,000 Added 7.73%	4,879,500 $309 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $250 Million - $289 Million	4,529,500	4,529,500 $289 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

Stay updated on Sessa Capital Im, L.P. with notifications on news.